Double Bond Pharmaceutical Competitors and Similar CompaniesClear all
Double Bond Pharmaceutical's competitors and similar companies include Turning Point Therapeutics and AbelZeta.
 Double Bond Pharmaceutical Double Bond Pharmaceutical is a company that develops approaches for treatment of cancers. |  Turning Point Therapeutics Turning Point Therapeutics (TP Therapeutics) is a precision oncology company that is engaged in medicine discovery for cancer and other diseases. |  AbelZeta AbelZeta (formerly known as Cellular Biomedicine Group) is a biopharmaceutical company that develops therapeutic solutions. | |
Founding Date | Founding Date 2014 | Founding Date 2013 | Founding Date 2009 |
Type | Type Public | Type Subsidiary | Type Private |
Tags | |||
Locations | Locations Uppsala, SE HQ Uppsala, SE | Locations San Diego, US HQ | Locations Rockville, US HQ Shanghai, CN |
Employees | Employees 1318% increase | Employees 474% decrease | Employees 1261% decrease |
Financial | |||
Revenue (est.) | Revenue (est.) kr84k (FY, 2025) | Revenue (est.) $30.8m (FY, 2021) | Revenue (est.) N/A |
Net income | Net income (kr333k) (FY, 2025) | Net income ($236.6m) (FY, 2021) | Net income N/A |
Funding | |||
Total funding raised | Total funding raised $ 81.7k | Total funding raised $ 144.4m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Turning Point Therapeutics
HQ
San Diego, US
Turning Point Therapeutics (TP Therapeutics) is a precision oncology company that is engaged in medicine discovery for cancer and other diseases.
View companyAbelZeta
HQ
Rockville, US
Employees
126↓ 1% decrease
AbelZeta (formerly known as Cellular Biomedicine Group) is a biopharmaceutical company that develops therapeutic solutions.
View company